MEDULLOBLASTOMAS

GOKALP H., ARASIL E., KANPOLAT Y., ERDOGAN A., DEDA H., UNLU A.

NEUROCHIRURGIA, vol.36, no.3, pp.87-89, 1993 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 36 Issue: 3
  • Publication Date: 1993
  • Doi Number: 10.1055/s-2008-1053802
  • Journal Name: NEUROCHIRURGIA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
  • Page Numbers: pp.87-89
  • Keywords: BRAIN TUMOR, MEDULLOBLASTOMA, RADIOTHERAPY, CHEMOTHERAPY, BRAIN SURGERY, RECURRENT MEDULLOBLASTOMA, NEUROECTODERMAL TUMORS, SURVIVAL, RADIOTHERAPY, CHEMOTHERAPY, PROGNOSIS, THERAPY, SURGERY
  • Ankara University Affiliated: Yes

Abstract

81 patients with biopsiy proven medulloblastoma with a mean age of 11.4 years were reviewed. Total removal of the tumour was accomplished in 18 cases (22.2 %), subtotal removal in 55 cases (67.9 %) and biopsy alone in 8 cases (9.9 %). 34 patients (27.5 %) had a recurrence of the tumour and 8 patients underwent a second posterior fossa exploration at the time of recurrence. In patients with total resection, five-year survival was 27.7 %. With partial resection, five-year survival decreased to 14.5 %. In patients with radiotherapy chemotherapy, 21.4 % survived 5 years after treatment but this rate decreased to 18.4 % in patients treated with radiotherapy only. The surgical mortality rate was 12.3 %.